Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Sclerotherapy & Endoscopic Needles

K-Number: K222006 · 2023-04-03

Decision Date2023-04-03
Product CodeFBK
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Sclerotherapy & Endoscopic Needles is the device name listed in this FDA 510(k) record. The listed applicant is G-Flex Europe Sprl. It received FDA 510(k) clearance on 2023-04-03 under 510(k) number K222006. The device is classified under product code FBK. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Sclerotherapy & Endoscopic Needles?

Sclerotherapy & Endoscopic Needles is a medical device that received FDA 510(k) clearance on 2023-04-03. The listed applicant is G-Flex Europe Sprl. The 510(k) number is K222006.

When did Sclerotherapy & Endoscopic Needles receive FDA 510(k) clearance?

Sclerotherapy & Endoscopic Needles received FDA 510(k) clearance on 2023-04-03, under 510(k) number K222006.

Who is the listed applicant for Sclerotherapy & Endoscopic Needles?

The FDA 510(k) record lists G-Flex Europe Sprl as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Sclerotherapy & Endoscopic Needles?

The FDA product code for Sclerotherapy & Endoscopic Needles is FBK.

Other records listing G-Flex Europe Sprl as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: FBK)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.